June 10, 2019 by Chain Drug Review
APhA, DIR Reform, FMI, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, NACDS, NASP, NCPA, NGA
Leading Headlines, Pharmacy

WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to
June 3, 2019 by Chain Drug Review
Alex Gourlay, APhA, Walgreens Boots Aliance
Issue 06-03-2019, News

DEERFIELD, Ill. — Walgreens this month announced it will train some of its pharmacists and other employees in understanding risk factors and warning signs for mental health and addiction concerns as well as strategies for helping individuals in crisis and noncrisis situations. Walgreens said its participation in the Mental Health First Aid program will be
August 11, 2017 by Bill Schiffner
American Pharmacists Association, American Pharmacists Month, APhA, Leadership360 Institute, Manage360, Mentor360, Thomas Menighan
Pharmacy, Retail News

WASHINGTON — The American Pharmacists Association (APhA) has unveiled the Leadership360 Institute, an educational program to help pharmacists enhance their leadership and management skills. Institute participants can sign up for any or all of the three Leadership tracks, including Lead360, Mentor360 and Manage360. Each track will offer programs to help pharmacists excel in their individual
February 1, 2017 by CDR Blog and Chain Drug Review
American Pharmacists Association, APhA, Department of Health and Human Services, Donald Trump, HHS secretary nominee, Pharmacy and Medically Underserved Areas Enhancement Act, provider status, Tom Menighan, Tom Price
CDR Blog

Rep. Tom Price (R., Ga.) had a tense confirmation hearing in the Senate last week for his nomination by President Donald Trump as secretary of the Department of Health and Human Services (HHS). But he got a thumbs-up from the American Pharmacists Association (APhA) on at least one count: pharmacists’ place in the U.S. health
September 16, 2016 by Chain Drug Review
American Pharmacists Association, APhA, Austin Scott, Dave Loebsack, Doug Collins, Earl "Buddy" Carter, H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act, pharmacy provider status, S. 314, video
Videos

(*Note: Segment begins at 00:21 of clip. Video courtesy of C-Span.) Earlier this week, several congressman voice their support for the pharmacy profession on the floor of the House of Representatives, the American Pharmacists Association (APhA) reported. Speaking during an hour-long Special Order on pharmacy issues, Rep. Earl “Buddy” Carter (R., Ga.) — the only
August 2, 2016 by Chain Drug Review
American Pharmacists Association, APhA, biologic drugs, biosimilars, FDA and NIH Workforce Authorities Modernization Act, S. 2700, Stacie Maass, U.S. Pharmacopeia, USP
Leading Headlines, Pharmacy, Retail News

WASHINGTON — A coalition of pharmacy industry organizations has asked congressional leaders to weigh proposals that would free certain biologic drugs from adherence to U.S. Pharmacopeia (USP) standards. This week, the American Pharmacists Association (APhA) and eight other groups sent a letter to the chairman and ranking members of key House and Senate committees expressing
July 18, 2016 by Chain Drug Review and Chain Drug Review
American Pharmacists Association, Amgen, APhA, APhA Academy of Student Pharmacists, APhA-ASP, APhA-ASP Summer Leadership Institute, Cardinal Health, Rite Aid
Leading Headlines, Pharmacy, Retail News

WASHINGTON — Over the weekend, the American Pharmacists Association (APhA) gave pharmacy students an opportunity for their voices to be heard on Capitol Hill. The APhA Academy of Student Pharmacists (APhA-ASP), supported by Rite Aid, Cardinal Health and Amgen, hosted leadership and professional development programming in Washington, D.C., for 240 pharmacy students. Running Friday to
June 24, 2016 by Chain Drug Review
American Pharmacists Association, APhA, H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act, Ron Kind, S. 314, Thomas Menighan, Todd Young
Leading Headlines, Pharmacy, Retail News, Uncategorized

WASHINGTON — The American Pharmacists Association (APhA) applauded remarks by two congressmen in support of pharmacist provider status legislation. APhA said Reps. Ron Kind (D., Wis.) and Todd Young (R., Ind.) issued statements this week to the House Ways and Means Subcommittee on Health calling for pharmacists to have a bigger role in health care.
May 3, 2016 by Chain Drug Review
American Pharmacists Association, APhA, APhA Institute on Alcoholism and Drug Dependencies, medication disposal, naloxone, prescription drug abuse, Richard Ashworth, Thomas Menighan, Walgreens
Leading Headlines, Pharmacy, Retail News

WASHINGTON — Walgreens has teamed up with the American Pharmacists Association (APhA) to battle prescription drug abuse. Through the collaboration, the APhA Institute on Alcoholism and Drug Dependencies will continue to offer a substance abuse education program for pharmacists and student pharmacists. The four-day educational program, which will provide pharmacy professionals with key information and
April 1, 2016 by Chain Drug Review
American Pharmacists Association, APhA, APhA Academy of Student Pharmacists, Cardinal Health, Cardinal Health Foundation, Generation Rx, Ohio State University College of Pharmacy, prescription medication abuse
Leading Headlines, Pharmacy, Retail News

DUBLIN, Ohio — Student pharmacists from across the country and a clinical professor of pharmacy were honored by the Cardinal Health Foundation, Ohio State University College of Pharmacy and American Pharmacists Association (APhA) for their efforts in preventing prescription medication abuse and misuse. Cardinal Health said Friday that the recognitions are part of Generation Rx,
March 18, 2016 by Chain Drug Review
American Pharmacists Association, APhA, Centers for Disease Control and Prevention, medication overdosing in children, National Electronic Injury Surveillance System-Cooperative Adverse Event Surveillance System, NEISS-CADES, oral liquid medications, PROTECT initiative
Leading Headlines, Pharmacy, Retail News

WASHINGTON — The American Pharmacists Association (APhA) plans to adopt a new policy on the labeling and measurement of oral liquid medications. APhA said Thursday that more than 300 members of its House of Delegates voted to move away from outdated dosing cups and teaspoons in favor of oral syringes and cups with metric system
March 16, 2016 by Chain Drug Review
American Pharmacists Association, APhA, CDC, Centers for Disease Control and Prevention, chronic pain, Jenna Ventresca, opioid abuse, opioid therapy
Leading Headlines, Pharmacy, Retail News

WASHINGTON — The American Pharmacists Association (APhA) has voiced its support of final guidelines from the Centers for Disease Control and Prevention (CDC) that aim to help prescribers improve the care and safety of patients being treated for chronic pain. APhA said late Tuesday that the CDC recommendations are directed at primary care clinicians who prescribe
March 2, 2016 by Chain Drug Review
American Pharmacists Association, APhA, controlled substances, Jenna Ventresca, opioid crisis
Pharmacy, Retail News

WASHINGTON — The American Pharmacists Association (APhA) has gone live with an online resource center to serve as a one-stop shop for pharmacists who want to learn more about opioid use, abuse and misuse. The Resource Center, accessed via the APhA website, will help educate pharmacists by identifying learning opportunities, highlighting clinical and patient resources,
October 12, 2015 by Chain Drug Review
American Pharmacists Association, APhA, H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act, S. 314, Thomas Menighan
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Congressional support continues to mount for the pharmacy industry’s push for pharmacists to be designated as health care providers. The American Pharmacists Association (APhA) reported that a majority of the U.S. House of Representatives now support the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592), or the so-called provider status bill. Overall,